James G. Bender serves as Executive at ImmunoCellular Therapeutics, Ltd., where they oversee executive responsibilities. Since joining the company, James G. Bender has executed 16 insider transactions totaling $118.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 30, 2015 involved selling 11,274 shares valued at $64.9K.
James G. Bender currently holds 88,726 shares of ImmunoCellular Therapeutics, Ltd. (IMUC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James G. Bender has been a net seller of IMUC stock. They have purchased $0 and sold $118.5K worth of shares.
James G. Bender's most recent insider trade was on Sep 30, 2015, when they sold 11,274 shares at $5.76 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 29, 2013 | IMUC | $2.7K | Sale | 900 | $3.00 | Discretionary |
| Aug 28, 2013 | IMUC | $14.2K | Sale | 5,000 | $2.84 | Discretionary |
| Aug 28, 2013 | IMUC | $9.4K | Sale | 3,303 | $2.85 | Discretionary |
| Aug 28, 2013 | IMUC | $19.0K | Payment | 6,376 | $2.98 | Discretionary |
| Aug 28, 2013 | IMUC | $14.4K | Sale | 5,000 | $2.88 | Discretionary |
| Aug 28, 2013 | IMUC | $19.0K | Option Exercise | 20,000 | $0.95 | Discretionary |
| Jun 1, 2012 | IMUC | $2.2K | Sale | 600 | $3.61 | Discretionary |
| Jun 1, 2012 | IMUC | $5.4K | Sale | 1,500 | $3.59 | Discretionary |
| Jun 1, 2012 | IMUC | $17.6K | Sale | 4,900 | $3.60 | Discretionary |
| Jun 1, 2012 | IMUC | $17.6K | Sale | 4,900 | $3.60 | Discretionary |
| Jun 1, 2012 | IMUC | $2.2K | Sale | 600 | $3.61 | Discretionary |
| Jun 1, 2012 | IMUC | $5.4K | Sale | 1,500 | $3.59 | Discretionary |
| May 31, 2012 | IMUC | $788 | Sale | 200 | $3.94 | Discretionary |
| May 31, 2012 | IMUC | $26.7K | Sale | 6,800 | $3.92 | Discretionary |